Foundation Medicine, Inc.

Formerly NASDAQ: FMI
Search in Documents
Key Exhibits
External Links
4 Foundation Medicine, Inc. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.1
from 10-Q/A 33 pages Amended and Restated Supply, Service, and Support Agreement
12/34/56
EX-10.2
from 10-Q 12 pages China Territory Agreement
12/34/56
EX-10.1
from 10-Q 33 pages Amended and Restated Supply, Service, and Support Agreement
12/34/56
EX-10.1
from 10-Q/A 68 pages Amended and Restated Ex-US Commercialization Agreement
12/34/56
EX-10.4
from 10-Q 21 pages September 12, 2016 Melanie Nallicheri Re:employment With Foundation Medicine, Inc. Dear Melanie: On Behalf of Foundation Medicine, Inc. (“Foundation Medicine” or “The Company”), I Am Very Pleased to Offer You the Position of Chief Business Officer and Head, Biopharma. the Terms of Your Position With the Company Are as Set Forth Below in This Letter Agreement (“Agreement”)
12/34/56
EX-10.3
from 10-Q 37 pages May 1, 2018 Konstantin Fiedler Re: Employment With FMI Germany Gmbh and Foundation Medicine, Inc
12/34/56
EX-10.2
from 10-Q 23 pages December 5, 2016 Michael Doherty Re: Employment With Foundation Medicine, Inc. Dear Michael: On Behalf of Foundation Medicine, Inc. (“Foundation Medicine” or “The Company”), I Am Very Pleased to Offer You the Position of Head of Product Development. the Terms of Your Position With the Company Are as Set Forth Below in This Letter Agreement (“Agreement”)
12/34/56
EX-10.1
from 10-Q 63 pages Amended and Restated Ex-US Commercialization Agreement
12/34/56
EX-10.31
from 10-K 3 pages Third Amendment to Ex-US Commercialization Agreement
12/34/56
EX-10.30
from 10-K 5 pages Second Amendment to Ex-US Commercialization Agreement
12/34/56
EX-10.27
from 10-K 2 pages Sixth Amendment to Collaboration Agreement
12/34/56
EX-10.1
from 8-K 13 pages Re: Employment With Foundation Medicine, Inc. Dear Tom: On Behalf of Foundation Medicine, Inc. (“Foundation Medicine” or “The Company”), I Am Very Pleased to Offer You Employment With the Company in the Position of Chief Commercial Officer. the Terms of Your Position With the Company Are as Set Forth Below in This Letter Agreement (“Agreement”)
12/34/56
EX-10.1
from 8-K 2 pages Fifth Amendment to Collaboration Agreement
12/34/56
EX-10.1
from 10-Q 2 pages Amendment #2 to Supply, Service, and Support Agreement
12/34/56
EX-10.11
from 10-K/A 7 pages Amendment #1 to Supply, Service, and Support Agreement
12/34/56
EX-10.24
from 10-K 2 pages Fourth Amendment to Collaboration Agreement
12/34/56
EX-10.11
from 10-K 7 pages Amendment #1 to Supply, Service, and Support Agreement
12/34/56
EX-10.4
from 8-K 3 pages Waiver and Consent January 5, 2017
12/34/56
EX-10.3
from 8-K 4 pages January 5, 2017 Steven Kafka Re: Retention Bonus Dear Steve
12/34/56
EX-10.2
from 8-K 6 pages January 5, 2017 Michael Pellini, M.D. 33841 Niguel Shores Drive Dana Point, Ca 92629 Dear Dr. Pellini: This Letter Is Intended to Memorialize the Understanding Regarding the Ending of Your Employment With Foundation Medicine, Inc. (“Foundation Medicine” or the “Company”) and Your Continuing Role as an Active Member of the Company’s Board of Directors (The “Board”)
12/34/56